Pharmaceutical News and Articles

FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara

Reported Use of Most Drugs Among Adolescents Remained Low in 2024

New NIH-funded data show lower use of most substances continues following the COVID-19 pandemic. If you or someone you know is struggling or in crisis, help is

San Antonio Breast Cancer Symposium, Dec. 10 to 13

The annual San Antonio Breast Cancer Symposium was held from Dec. 10 to 13 in San Antonio. Attendees included medical oncologists, radiation oncologists, resear

Prevalence of Infant Nonsupine Sleep Position Steady From 2016 to 2022

The overall prevalence of nonsupine sleep positions during infancy has been steady over time (2016 to 2022), according to a research letter published online Dec

Breast Cancer Risk Increased With Weight Gain After Age 35 Years

The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology Medicine. Kathe

Postmenopausal Women Have Higher Risk for Developing Rheumatoid Arthritis

Postmenopausal women, particularly those who experience early menopause, may have a higher risk for developing rheumatoid arthritis (RA), according to a review

RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults

Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years

Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu

have now been confirmed in seven states.California accounts for the largest share of human bird flu cases in the country, with 34 confirmed infections. Washingt

Certain Foods May Cut Risk for Rheumatoid Arthritis

Moderate alcohol consumption and eating oily fish, fruits, and cereals may reduce the risk for rheumatoid arthritis (RA), according to a review published online

Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer

Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor and did not improve from 2018 to 2020,